BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15111325)

  • 1. Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
    Varley CL; Stahlschmidt J; Smith B; Stower M; Southgate J
    Am J Pathol; 2004 May; 164(5):1789-98. PubMed ID: 15111325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
    Varley CL; Stahlschmidt J; Lee WC; Holder J; Diggle C; Selby PJ; Trejdosiewicz LK; Southgate J
    J Cell Sci; 2004 Apr; 117(Pt 10):2029-36. PubMed ID: 15054105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Guan YF; Zhang YH; Breyer RM; Davis L; Breyer MD
    Neoplasia; 1999 Oct; 1(4):330-9. PubMed ID: 10935488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.
    Cha BS; Ciaraldi TP; Carter L; Nikoulina SE; Mudaliar S; Mukherjee R; Paterniti JR; Henry RR
    Diabetologia; 2001 Apr; 44(4):444-52. PubMed ID: 11357475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limited cooperation between peroxisome proliferator-activated receptors and retinoid X receptor agonists in sebocyte growth and development.
    Kim MJ; Deplewski D; Ciletti N; Michel S; Reichert U; Rosenfield RL
    Mol Genet Metab; 2001 Nov; 74(3):362-9. PubMed ID: 11708867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial differentiation in chronically urine-deprived bladders of patients with end-stage renal disease.
    Stahlschmidt J; Varley CL; Toogood G; Selby PJ; Southgate J
    Kidney Int; 2005 Sep; 68(3):1032-40. PubMed ID: 16105033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
    Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
    Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor-gamma ligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration.
    Goetze S; Kintscher U; Kim S; Meehan WP; Kaneshiro K; Collins AR; Fleck E; Hsueh WA; Law RE
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):909-21. PubMed ID: 11707695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells.
    Marra F; Efsen E; Romanelli RG; Caligiuri A; Pastacaldi S; Batignani G; Bonacchi A; Caporale R; Laffi G; Pinzani M; Gentilini P
    Gastroenterology; 2000 Aug; 119(2):466-78. PubMed ID: 10930382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells.
    Satoh T; Toyoda M; Hoshino H; Monden T; Yamada M; Shimizu H; Miyamoto K; Mori M
    Oncogene; 2002 Mar; 21(14):2171-80. PubMed ID: 11948400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human peroxisome-proliferator-activated receptor-gamma is activated by inducers of adipogenesis, including thiazolidinedione drugs.
    Lambe KG; Tugwood JD
    Eur J Biochem; 1996 Jul; 239(1):1-7. PubMed ID: 8706692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.
    Kitamura S; Miyazaki Y; Shinomura Y; Kondo S; Kanayama S; Matsuzawa Y
    Jpn J Cancer Res; 1999 Jan; 90(1):75-80. PubMed ID: 10076568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling cell signalling and differentiation in the urothelium.
    Woodroffe PJ; King JR; Varley CL; Southgate J
    Bull Math Biol; 2005 Mar; 67(2):369-89. PubMed ID: 15710185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation.
    Pizzimenti S; Laurora S; Briatore F; Ferretti C; Dianzani MU; Barrera G
    Free Radic Biol Med; 2002 Feb; 32(3):233-45. PubMed ID: 11827749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma.
    Mössner R; Schulz U; Krüger U; Middel P; Schinner S; Füzesi L; Neumann C; Reich K
    J Invest Dermatol; 2002 Sep; 119(3):576-82. PubMed ID: 12230498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice.
    Memon RA; Tecott LH; Nonogaki K; Beigneux A; Moser AH; Grunfeld C; Feingold KR
    Endocrinology; 2000 Nov; 141(11):4021-31. PubMed ID: 11089532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunophenotype of transitional metaplasia of the uterine cervix.
    Harnden P; Kennedy W; Andrew AC; Southgate J
    Int J Gynecol Pathol; 1999 Apr; 18(2):125-9. PubMed ID: 10202669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unliganded RXR acts as an inhibitory factor on troglitazone-induced activation.
    Monden T; Yamada M; Nihei Y; Kishi M; Tomaru T; Ishii S; Hashida T; Shibusawa N; Hashimoto K; Satoh T; Kasai K; Mori M
    Life Sci; 2004 Dec; 76(7):731-41. PubMed ID: 15581905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.